Acid-Sensitive Nanoparticles Based on Molybdenum Disulfide for Photothermal-Chemo Therapy
Lists
Only you see this
Abstract
The combination of multiple treatments has recently been investigated for tumor treatment. In this study, molybdenum disulfide (MoS<sub>2</sub>) with excellent photothermal conversion performance was used as the core, and manganese dioxide (MnO<sub>2</sub>), which responds to the tumor microenvironment, was loaded on its surface by liquid deposition to form a mesoporous core-shell structure. Then, the chemotherapeutic drug Adriamycin (DOX) was loaded into the hole. To further enhance its water solubility and stability, the surface of MnO<sub>2</sub> was modified with mPEG-NH<sub>2</sub> to prepare the combined antitumor nanocomposite MoS<sub>2</sub>@DOX/MnO<sub>2</sub>-PEG (MDMP). The results showed that MDMP had a diameter of about 236 nm, its photothermal conversion efficiency was 33.7%, and the loading and release rates of DOX were 13 and 65%, respectively. During <i>in vivo</i> and <i>in vitro</i> studies, MDMP showed excellent antitumor activity. Under the combined treatment, the tumor cell viability rate was only 11.8%. This nanocomposite exhibits considerable potential for chemo-photothermal combined antitumor therapy.
BibTeX
@inproceedings{liu2022acid,
author = {Qin Liu and Ping Song and Weiwei Zhang and Zhenyu Wang and Kai Yang and Jianquan Luo and Longbao Zhu and Lin Gui and Yugui Tao and Fei Ge},
title = {{Acid-Sensitive Nanoparticles Based on Molybdenum Disulfide for Photothermal-Chemo Therapy}},
booktitle = {ACS},
year = {2022},
doi = {10.1021/acsbiomaterials.1c01390},
}Loading related content...